Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin in HCV Genotype 1 Partial Responders
NCT00814606Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Feb 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of fluvastatin in hepatitis C (HCV), sponsored by University of Chicago. Planned start Feb 2010; status: withdrawn.
02
Drugs
fluvastatin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00814606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814606.